Product image of Hyplaxy (Hydroxychloroquine Sulfate) supplied by GNH India

Hyplaxy

Active Ingredient:
Hydroxychloroquine Sulfate
Origin:
EU

Hyplaxy (Hydroxychloroquine Sulfate)

Hydroxychloroquine Sulfate, the active ingredient in Hyplaxy, is an antimalarial presented as an oral tablet for oral use. It is employed to treat malaria and to manage autoimmune conditions such as rheumatoid arthritis and systemic lupus erythematosus in adult patients.

GNH India supplies Hyplaxy as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers. All batches are manufactured under EU GMP guidelines and undergo rigorous testing before release.

Manufacturer / TM Owner

Makpharm D.O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Hydroxychloroquine Sulfate is used in the treatment of parasitic infections and autoimmune diseases.

  • Malaria: Reduces parasitic load and prevents disease progression.
  • Rheumatoid arthritis: Decreases joint inflammation and slows disease progression.
  • Systemic lupus erythematosus: Controls disease activity and reduces flare frequency.

How It Works

  • Hydroxychloroquine Sulfate accumulates in lysosomes, raising the internal pH and inhibiting enzymatic activity required for antigen processing. This disruption impairs autophagy and reduces presentation of immune complexes, thereby modulating the immune response. In malaria parasites, the drug interferes with heme polymerization, leading to toxic accumulation of free heme and parasite death. Additionally, the drug interferes with Toll‑like receptor signaling, further dampening inflammatory pathways.

Side Effects

Hydroxychloroquine Sulfate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Nausea: mild gastrointestinal upset.
  • Headache: transient cranial discomfort.
  • Diarrhea: loose stools.
  • Skin rash: mild erythema or itching.
  • Visual disturbance: blurred vision or difficulty focusing.

Serious or Rare Side Effects

  • Retinal toxicity: irreversible vision loss requiring ophthalmologic monitoring.
  • Cardiac arrhythmia: QT prolongation and potential ventricular tachycardia.
  • Severe hypoglycemia: especially in diabetic patients on insulin.
  • Hemolytic anemia: in individuals with G6PD deficiency.
  • Neuropsychiatric effects: agitation, confusion or mood changes.

Precautions & Warnings

Before prescribing Hydroxychloroquine Sulfate, clinicians should consider several safety measures.

  • Baseline eye exam: obtain ophthalmologic assessment prior to therapy.
  • Cardiac monitoring: evaluate ECG for QT interval in patients with cardiac risk.
  • Renal function: adjust dose if significant impairment is present.
  • Concomitant medications: review for drugs that may prolong QT interval.
  • Pregnancy and lactation: weigh potential risks against benefits; use only if clearly indicated.
  • Store at ambient temperature: keep below 25 °C, protect from moisture and light in original packaging.

Avoid Interactions

Hydroxychloroquine Sulfate interacts with several medicines, requiring careful management.

Major Interactions (Avoid)

  • Antacids containing aluminum or magnesium: reduce absorption of hydroxychloroquine.
  • Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): markedly decrease drug levels.
  • QT‑prolonging agents (e.g., quinidine, amiodarone): increase risk of cardiac arrhythmias.
  • Digoxin: may increase serum digoxin concentrations.
  • Azithromycin: combined use heightens QT prolongation risk.

Moderate Interactions (Monitor Closely)

  • Antimalarial combination (e.g., artesunate): potential additive toxicity.
  • Anticoagulants (warfarin): may enhance anticoagulant effect.
  • Antidiabetic agents (insulin, sulfonylureas): increase risk of hypoglycemia.
  • Corticosteroids: may augment immunosuppressive effect.

Frequently Asked Questions

Hyplaxy contains hydroxychloroquine sulfate and is indicated for the treatment of malaria as well as for managing autoimmune conditions such as rheumatoid arthritis and systemic lupus erythematosus. It helps reduce disease activity and control symptoms in these disorders.

Hydroxychloroquine accumulates in lysosomes, raising their pH and interfering with enzymes involved in antigen processing. This limits autophagy and reduces presentation of immune complexes, thereby modulating the immune response. In malaria parasites, it disrupts heme polymerization, leading to parasite death.

The appropriate dose of Hyplaxy is individualized by the prescribing healthcare professional based on the specific indication, patient weight, renal function, and other clinical factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of hydroxychloroquine during pregnancy or lactation has not been definitively established. It may be used only when the potential benefits outweigh the possible risks, and the decision should be made by a qualified clinician after careful assessment.

To request Hyplaxy, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Hyplaxy (hydroxychloroquine) shares a similar mechanism with chloroquine but generally has a better safety profile and is also approved for autoimmune diseases. Compared with newer biologic agents, it is less expensive and administered orally, though its efficacy may be lower for severe disease.

Hyplaxy should be stored at ambient temperature, preferably below 25 °C, in its original container to protect it from moisture and light. Keep the medication out of reach of children and avoid storing it in bathrooms or other humid environments.

Hyplaxy is taken orally, usually as a tablet, with or without food as directed by the prescriber. The exact administration schedule, such as once or twice daily, is determined by the treating clinician based on the condition being treated.

Serious risks include retinal toxicity, which can lead to irreversible vision loss, and cardiac arrhythmias such as QT prolongation. Severe hypoglycemia and hemolytic anemia in patients with G6PD deficiency are also important concerns that require monitoring.

Hyplaxy is contraindicated in patients with known hypersensitivity to hydroxychloroquine or related compounds, those with pre‑existing retinal disease, and individuals with significant G6PD deficiency. Caution is also advised for patients with severe cardiac conduction disorders.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Hydroxychloroquine Sulfate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT